Original Source(s)
Related Content
Postoperative Step Counts Tied to Surgical Recovery
Wearable-measured mobility—but not heart rate variability or wellness scores—was associated with length of stay, complications, and readmissions
May 6, 2026
-
3 min
FDA Okays Weekly Option in Achondroplasia
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
March 2, 2026
-
2 min